Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mar Drugs ; 18(12)2020 Nov 30.
Artigo em Inglês | MEDLINE | ID: mdl-33265937

RESUMO

Fibrodysplasia ossificans progressiva (FOP) is a rare congenital disorder with heterotopic ossification (HO) in soft tissues. The abnormal activation of bone morphogenetic protein (BMP) signaling by a mutant activin receptor-like kinase-2 (ALK2) leads to the development of HO in FOP patients, and, thus, BMP signaling inhibitors are promising therapeutic applications for FOP. In the present study, we screened extracts of 188 Indonesian marine invertebrates for small molecular inhibitors of BMP-induced alkaline phosphatase (ALP) activity, a marker of osteoblastic differentiation in a C2C12 cell line stably expressing ALK2(R206H) (C2C12(R206H) cells), and identified five marine sponges with potent ALP inhibitory activities. The activity-guided purification of an EtOH extract of marine sponge Dysidea sp. (No. 256) resulted in the isolation of dysidenin (1), herbasterol (2), and stellettasterol (3) as active components. Compounds 1-3 inhibited ALP activity in C2C12(R206H) cells with IC50 values of 2.3, 4.3, and 4.2 µM, respectively, without any cytotoxicity, even at 18.4-21.4 µM. The direct effects of BMP signaling examined using the Id1WT4F-luciferase reporter assay showed that compounds 1-3 did not decrease the reporter activity, suggesting that they inhibit the downstream of the Smad transcriptional step in BMP signaling.


Assuntos
Fosfatase Alcalina/antagonistas & inibidores , Diferenciação Celular/efeitos dos fármacos , Dysidea/metabolismo , Inibidores Enzimáticos/farmacologia , Mioblastos Esqueléticos/efeitos dos fármacos , Miosite Ossificante/tratamento farmacológico , Osteoblastos/efeitos dos fármacos , Osteogênese/efeitos dos fármacos , Esteróis/farmacologia , Tiazóis/farmacologia , Fosfatase Alcalina/metabolismo , Animais , Proteína Morfogenética Óssea 4/toxicidade , Linhagem Celular , Inibidores Enzimáticos/isolamento & purificação , Indonésia , Camundongos , Estrutura Molecular , Mioblastos Esqueléticos/metabolismo , Mioblastos Esqueléticos/patologia , Miosite Ossificante/metabolismo , Miosite Ossificante/patologia , Osteoblastos/metabolismo , Osteoblastos/patologia , Esteróis/isolamento & purificação , Relação Estrutura-Atividade , Tiazóis/isolamento & purificação
2.
Sci Rep ; 3: 1753, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23628927

RESUMO

For biosynthesis of bacillamide C by Bacillus atrophaeus C89 associated with South China sea sponge Dysidea avara, it is hypothesized that decarboxylation from L-tryptophan to tryptamine could be performed before amidation by the downstream aromatic L-amino acid decarboxylase (AADC) to the non-ribosomal peptide synthetases (NRPS) gene cluster for biosynthesizing bacillamide C. The structural analysis of decarboxylases' known substrates in KEGG database and alignment analysis of amino acid sequence of AADC have suggested that L-tryptophan and L-phenylalanine are the potential substrates of AADC. The enzymatic kinetic experiment of the recombinant AADC proved that L-tryptophan is a more reactive substrate of AADC than L-phenylalanine. Meanwhile, the AADC-catalyzed conversion of L-tryptophan into tryptamine was confirmed by means of HPLC and LC/MS. Thus during bacillamide C biosynthesis, the decarboxylation of L-tryptophan to tryptamine is likely conducted first under AADC catalysis, followed by the amidation of tryptamine with the carboxylic product of NRPS gene cluster.


Assuntos
Descarboxilases de Aminoácido-L-Aromático/metabolismo , Bacillus/metabolismo , Triptaminas/biossíntese , Sequência de Aminoácidos , Animais , Descarboxilases de Aminoácido-L-Aromático/genética , Bacillus/enzimologia , Bacillus/genética , Descarboxilação , Dysidea/genética , Dysidea/metabolismo , Dados de Sequência Molecular , Peptídeo Sintases/genética , Peptídeo Sintases/metabolismo , Fenilalanina/genética , Fenilalanina/metabolismo , Alinhamento de Sequência , Tiazóis/metabolismo , Triptaminas/metabolismo , Triptofano/genética , Triptofano/metabolismo
3.
Mar Drugs ; 8(6): 1731-42, 2010 May 26.
Artigo em Inglês | MEDLINE | ID: mdl-20631865

RESUMO

Marine sponges produce secondary metabolites that can be used as a natural source for the design of new drugs and cosmetics. There is, however, a supply problem with these natural substances for research and eventual commercialisation of the products. In situ sponge aquaculture is nowadays one of the most reliable methods to supply pharmaceutical companies with sufficient quantities of the target compound. In this study, we focus on the aquaculture of the sponge Dysidea avara (Schmidt, 1862), which produces avarol, a sterol with interesting pharmaceutical attributes. The soft consistency of this species makes the traditional culture method based on holding explants on ropes unsuitable. We have tested alternative culture methods for D. avara and optimized the underwater structures to hold the sponges to be used in aquaculture. Explants of this sponge were mounted on horizontal ropes, inside small cages or glued to substrates. Culture efficiency was evaluated by determination of sponge survival, growth rates, and bioactivity (as an indication of production of the target metabolite). While the cage method was the best method for explant survival, the glue method was the best one for explant growth and the rope method for bioactivity.


Assuntos
Aquicultura/métodos , Dysidea/crescimento & desenvolvimento , Animais , Antibacterianos/metabolismo , Antibacterianos/farmacologia , Antineoplásicos/metabolismo , Antineoplásicos/farmacologia , Antivirais/metabolismo , Antivirais/farmacologia , Dysidea/metabolismo , Mar Mediterrâneo , Photobacterium/efeitos dos fármacos , Sesquiterpenos/metabolismo , Sesquiterpenos/farmacologia , Espanha , Análise de Sobrevida , Extratos de Tecidos/metabolismo , Extratos de Tecidos/farmacologia
4.
Org Lett ; 8(23): 5401-4, 2006 Nov 09.
Artigo em Inglês | MEDLINE | ID: mdl-17078728

RESUMO

[Structure: see text] Two approaches to the synthesis of (2S,4S)-5,5-dichloroleucine are compared, and the parent amino acid was used in the first total synthesis of the polychlorinated marine natural product, dysamide B. A key step was the lead tetraacetate-mediated decarboxylation of an alpha,alpha-dichloro acid in the presence of 1,4-cyclohexadiene to generate the dichloromethyl group.


Assuntos
Hidrocarbonetos Clorados/síntese química , Piperazinas/síntese química , Animais , Dysidea/metabolismo , Hidrocarbonetos Clorados/metabolismo , Estrutura Molecular , Piperazinas/metabolismo
5.
Chem Biol ; 12(3): 397-406, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15797223

RESUMO

Four species of marine sponges (Phylum Porifera, Order Dictyoceratida), which contain the filamentous cyanobacterial symbiont Oscillatoria spongeliae, were collected from four locations in Palau. The halogenated natural products associated with the symbiont were characterized from each sample, revealing that each species contained either chlorinated peptides, brominated diphenyl ethers, or no halogenated compounds. Analysis of the host sponges and the symbionts indicated that each species of sponge contained a distinct strain of morphologically similar cyanobacteria. Although cospeciation may be present in this group, we have identified that at least one host switching event has occurred in this symbiosis. Only the strain of O. spongeliae in the sponge containing the chlorinated compounds possessed genes involved in the biosynthesis of chlorinated leucine precursors, indicating that the chemical variation observed in these animals has a genetic foundation.


Assuntos
Cianobactérias/metabolismo , Dysidea/metabolismo , Dysidea/microbiologia , Simbiose/fisiologia , Animais , Palau , Filogenia , Especificidade da Espécie
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...